Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Trading Down 0.7% – Time to Sell?

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLXGet Free Report)’s share price traded down 0.7% on Friday . The stock traded as low as $14.89 and last traded at $14.89. 545 shares were traded during trading, a decline of 81% from the average session volume of 2,856 shares. The stock had previously closed at $15.00.

Analysts Set New Price Targets

TLX has been the subject of several research analyst reports. UBS Group initiated coverage on Telix Pharmaceuticals Limited American Depositary Shares in a research note on Friday, November 15th. They issued a “buy” rating and a $21.00 price objective for the company. William Blair upgraded shares of Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a research note on Tuesday, November 19th.

Read Our Latest Research Report on Telix Pharmaceuticals Limited American Depositary Shares

Telix Pharmaceuticals Limited American Depositary Shares Stock Down 0.5 %

Telix Pharmaceuticals Limited American Depositary Shares Company Profile

(Get Free Report)

Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.

Featured Articles

Receive News & Ratings for Telix Pharmaceuticals Limited American Depositary Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Telix Pharmaceuticals Limited American Depositary Shares and related companies with MarketBeat.com's FREE daily email newsletter.